These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 19104402

  • 1. A novel immunosuppressive strategy combined with preemptive antiviral therapy improves the eighteen-month mortality in HCV recipients transplanted with aged livers.
    Urbani L, Mazzoni A, Colombatto P, Bindi L, Biancofiore G, Tascini C, Menichetti F, Brunetto MR, Scatena F, Filipponi F.
    Transplantation; 2008 Dec 27; 86(12):1666-71. PubMed ID: 19104402
    [Abstract] [Full Text] [Related]

  • 2. Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss.
    Bahra M, Neumann UP, Jacob D, Langrehr JM, Neuhaus P.
    Transplant Proc; 2005 May 27; 37(4):1700-2. PubMed ID: 15919436
    [Abstract] [Full Text] [Related]

  • 3. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy.
    Manousou P, Samonakis D, Cholongitas E, Patch D, O'Beirne J, Dhillon AP, Rolles K, McCormick A, Hayes P, Burroughs AK.
    Liver Transpl; 2009 Dec 27; 15(12):1783-91. PubMed ID: 19938143
    [Abstract] [Full Text] [Related]

  • 4. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, Holt C, Lewin KJ, Busuttil RW, Martin P.
    Am J Gastroenterol; 1997 Sep 27; 92(9):1453-7. PubMed ID: 9317061
    [Abstract] [Full Text] [Related]

  • 5. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, Montejo M, Valdivieso A, Ruiz P, Gonzalez J, Ortiz de Urbina J.
    Transplant Proc; 2009 Apr 27; 41(3):1041-3. PubMed ID: 19376421
    [Abstract] [Full Text] [Related]

  • 6. Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up.
    Neumann UP, Berg T, Bahra M, Puhl G, Guckelberger O, Langrehr JM, Neuhaus P.
    Transplantation; 2004 Jan 27; 77(2):226-31. PubMed ID: 14742986
    [Abstract] [Full Text] [Related]

  • 7. Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression.
    Berenguer M, Aguilera V, Prieto M, San Juan F, Rayón JM, Benlloch S, Berenguer J.
    J Hepatol; 2006 Apr 27; 44(4):717-22. PubMed ID: 16487616
    [Abstract] [Full Text] [Related]

  • 8. Scarce influence of corticosteroid boluses on long-term viral load and liver histology in transplanted patients with recurrent hepatitis C.
    Barcena R, Oton E, Barreales M, Castillo M, Blesa C.
    Transplant Proc; 2006 Oct 27; 38(8):2502-4. PubMed ID: 17097981
    [Abstract] [Full Text] [Related]

  • 9. Steroid-free living donor liver transplantation in adults: impact on hepatitis C recurrence.
    Marubashi S, Dono K, Nagano H, Kim C, Asaoka T, Hama N, Kobayashi S, Takeda Y, Umeshita K, Monden M, Doki Y, Mori M.
    Clin Transplant; 2009 Oct 27; 23(6):904-13. PubMed ID: 19573088
    [Abstract] [Full Text] [Related]

  • 10. The use of extracorporeal photopheresis for allograft rejection in liver transplant recipients.
    Urbani L, Mazzoni A, Catalano G, De Simone P, Vanacore R, Pardi C, Bortoli M, Biancofiore G, Campani D, Perrone V, Mosca F, Scatena F, Filipponi F.
    Transplant Proc; 2004 Dec 27; 36(10):3068-70. PubMed ID: 15686696
    [Abstract] [Full Text] [Related]

  • 11. Influence of immunosuppression and effect of hepatitis C virus on new onset of diabetes mellitus in liver transplant recipients.
    Sánchez-Pérez B, Aranda Narváez JM, Santoyo Santoyo J, Fernández-Aguilar JL, Suárez Muñoz MA, González-Sánchez AJ, Pérez Daga JA, Ramírez Plaza CP, Carrasco Campos J, Jiménez Mazure C, Becerra Ortíz R.
    Transplant Proc; 2008 Nov 27; 40(9):2994-6. PubMed ID: 19010171
    [Abstract] [Full Text] [Related]

  • 12. Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection.
    Kugelmas M, Osgood MJ, Trotter JF, Bak T, Wachs M, Forman L, Kam I, Everson GT.
    Liver Transpl; 2003 Nov 27; 9(11):1159-65. PubMed ID: 14586876
    [Abstract] [Full Text] [Related]

  • 13. Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection.
    Kuo A, Tan V, Lan B, Khalili M, Feng S, Roberts JP, Terrault NA.
    Liver Transpl; 2008 Oct 27; 14(10):1491-7. PubMed ID: 18825708
    [Abstract] [Full Text] [Related]

  • 14. The importance of clinical parameters when differentiating cholestatic hepatitis C virus from allograft rejection.
    Neff GW, Shire N, Ruiz P, O'Brien C, Garcia M, Dela Garza J, Rudich SR, Reddy KR.
    Transplant Proc; 2005 Dec 27; 37(10):4397-402. PubMed ID: 16387130
    [Abstract] [Full Text] [Related]

  • 15. Rejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis.
    Samonakis DN, Mela M, Quaglia A, Triantos CK, Thalheimer U, Leandro G, Pesci A, Raimondo ML, Dhillon AP, Rolles K, Davidson BR, Patch DW, Burroughs AK.
    Transpl Infect Dis; 2006 Mar 27; 8(1):3-12. PubMed ID: 16623815
    [Abstract] [Full Text] [Related]

  • 16. Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation.
    Cescon M, Grazi GL, Cucchetti A, Vetrone G, Ravaioli M, Ercolani G, Morelli MC, Piscaglia F, Tamè M, Pinna AD.
    Liver Transpl; 2009 Jul 27; 15(7):782-9. PubMed ID: 19562715
    [Abstract] [Full Text] [Related]

  • 17. Survival outcome after hepatic retransplantation for hepatitis C virus-positive and -negative recipients.
    Jain A, Orloff M, Abt P, Kashyap R, Mohanka R, Lansing K, Romano J, Bozorgzadeh A.
    Transplant Proc; 2005 Sep 27; 37(7):3159-61. PubMed ID: 16213336
    [Abstract] [Full Text] [Related]

  • 18. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
    Charlton M, Seaberg E.
    Liver Transpl Surg; 1999 Jul 27; 5(4 Suppl 1):S107-14. PubMed ID: 10431024
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis C.
    Burra P.
    Semin Liver Dis; 2009 Feb 27; 29(1):53-65. PubMed ID: 19235659
    [Abstract] [Full Text] [Related]

  • 20. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation.
    McTaggart RA, Terrault NA, Vardanian AJ, Bostrom A, Feng S.
    Liver Transpl; 2004 Aug 27; 10(8):975-85. PubMed ID: 15390322
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.